x

#BCSM Blog

Understanding Lobular Breast Cancer

This week on the #BCSM chat, we’ll hear from  about Lobular Breast Cancer. The #BCSM team is pleased to share this guest post from Diane Mapes, @double_whammied: When I was diagnosed with breast cancer in early 2011, I was clueless. Clueless that there were different types of breast cancer. Clueless that mammograms weren’t foolproof. Clueless […]

Read more ›
#BCSM 2017 Wrap Up

19 December 2017 During the last chat of the year, we remembered and honored those who are no longer with us. In addition, #BCSM co-founder @stales reviewed the top breast cancer stories, from January through December. January: Third of Breast Cancer Patients Treated Unnecessarily February: Dense Breasts Eclipse All Other Known Breast Cancer Risk Factors […]

Read more ›
ASBrS 2017 – Key Topics by Dr. Deanna Attai
On: May 8, 2017
By: Alicia

Dr. Shelley Hwang from Duke University spoke on DCIS subtyping and overtreatment. She noted that DCIS now comprises over 20% of all mammographically detected breast cancer. It is considered a “non-obligate precursor” of invasive cancer – the rate and likelihood of progression to invasive cancer are not clearly known. However, it is clear that some […]

Read more ›
ASBrS 2017: Oncoplastics and Adequate Margins
On: May 8, 2017
By: Alicia

This guest post is from Dr. Aleksandra Popadich.  Dr. Popadich came all the way to Las Vegas from New Zealand because she watched Dr. Attai’s tweets from the 2016 conference! Oncoplastic surgery is going to become a part of breast surgeon’s repertoire. The development of these skills will enable us to achieve good local control and […]

Read more ›